Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders

被引:45
|
作者
Drake, RE
Xie, HY
McHugo, GJ
Shumway, M
机构
[1] Dartmouth Coll Sch Med, Dept Psychiat, Lebanon, NH USA
[2] Dartmouth Coll Sch Med, Dept Community & Family Med, Lebanon, NH USA
[3] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA
关键词
co-occurring disorders; bipolar and substance use disorders;
D O I
10.1016/j.biopsych.2004.08.020
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Little is known about the long-term outcomes of patients in the public mental health system who are disabled by co-occurring bipolar and substance use disorders. This article reports on the 3-year course of 51 patients with co-occurring bipolar and substance use disorders in the New Hampshire Dual Diagnosis Study, Participants received integrated dual disorders treatments in the state mental health system and were independently assessed with standardized measures at baseline and every 6 months for 3 years. Though psychiatric symptoms improved only modestly, participants improved steadily in terms of remission from substance abuse (61% in full remission at 3 years); they also achieved greater independent living (average 239 days in third year), competitive employment (49% in third year), regular social contacts with nonsubstance abusers (46% at 3 years), and quality of life (56% satisfied with life at 3 years). Different domains of outcome were only weakly related to each other. Long-term, disabled patients with co-occurring bipolar and substance use disorders have potential for remission from substance abuse and substantial improvements in functioning and quality of lift.
引用
收藏
页码:749 / 756
页数:8
相关论文
共 50 条
  • [41] Co-occurring Mental Illness and Substance-Use Disorders
    Pal, Somnath
    [J]. US PHARMACIST, 2019, 44 (11) : 15 - 15
  • [42] Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders
    Smelson, David A.
    Dixon, Lisa
    Craig, Thomas
    Remolina, Stephen
    Batki, Steven L.
    Niv, Noosha
    Owen, Richard
    [J]. CNS DRUGS, 2008, 22 (11) : 903 - 916
  • [43] Psychological interventions for co-occurring depression and substance use disorders
    Hides, Leanne
    Quinn, Catherine
    Stoyanov, Stoyan
    Kavanagh, David
    Baker, Amanda
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (11):
  • [44] Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders
    David A. Smelson
    Lisa Dixon
    Thomas Craig
    Stephen Remolina
    Steven L. Batki
    Noosha Niv
    Richard Owen
    [J]. CNS Drugs, 2008, 22 : 903 - 916
  • [45] TREATMENT OF YOUTH SUBSTANCE USE DISORDERS WITH CO-OCCURRING DEPRESSION
    Kaminer, Yifrah
    [J]. DRUG AND ALCOHOL REVIEW, 2017, 36 : 5 - 5
  • [46] Co-Occurring Substance Use Disorders and Grief during Recovery
    Scroggs, Lauren Bethune
    Goodwin, Lloyd R., Jr.
    McDougal, Jennifer J. Wright
    [J]. SUBSTANCE USE & MISUSE, 2022, 57 (03) : 418 - 424
  • [47] HIV risk behavior among patients with co-occurring bipolar and substance use disorders: Associations with mania and drug abuse
    Meade, Christina S.
    Graff, Fiona S.
    Griffin, Margaret L.
    Weiss, Roger D.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2008, 92 (1-3) : 296 - 300
  • [48] Ziprasidone monotherapy in adolescent co-occurring substance use and bipolar disorder
    Mech, Arnold
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (04): : 318 - 318
  • [49] Co-occurring bipolar and substance abuse disorders: what do we know?
    Volkow, N.
    [J]. BIPOLAR DISORDERS, 2011, 13 : 20 - 20
  • [50] SEXUAL ORIENTATION, CO-OCCURRING DISORDERS, AND SUBSTANCE ABUSE TREATMENT OUTCOMES
    Lipsky, S.
    Krupski, A.
    Lucenko, B.
    Huber, A.
    Mancuso, D.
    Roy-Byrne, P.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 282A - 282A